Paper7180965
Prognostic significance of morphologic parameters in renal cell carcinoma.
Fuhrman SA and 2 others. Am J Surg Pathol, 1982. Cited by 2,311 papers, by iCite.
Cite this record
ConductScience Library. Prognostic significance of morphologic parameters in renal cell carcinoma. Papers, record 7180965. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7180965
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adenocarcinoma | Major topic |
| Kidney Neoplasms | Major topic |
| Adult | |
| Aged | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Neoplasm Invasiveness | |
| Prognosis | |
| Renal Veins |
Source PubMed
Cited by743
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2,311 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42758284 | Quantitative MRI for World Health Organisation/International Society of Urological Pathology Grading of Renal Cell Carcinoma: a systematic review and diagnostic meta-analysis. | Eur Radiol | 2026 | https://conductscience.org/library/papers/42758284 | PubMed |
| 42656201 | Prognostic value of preoperative inflammatory cell-to-HDL cholesterol ratios in patients with non-metastatic clear cell renal cell carcinoma. | Front Oncol | 2026 | https://conductscience.org/library/papers/42656201 | PubMed |
| 42552493 | Risk-Adapted Use of Adjuvant Systemic Therapy After Nephrectomy for Renal Cell Carcinoma: A Population-Based Study in the Post-approval Era. | Ann Surg Oncol | 2026 | https://conductscience.org/library/papers/42552493 | PubMed |
| 42449624 | Risk Stratification in Renal Cell Carcinoma: A Narrative Review. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42449624 | PubMed |
| 42436714 | Multimodal deep learning for predicting WHO/ISUP grading in renal tumors on CT using a self-attention-based model: variable Vision Transformer (vViT). | Eur J Radiol Open | 2026 | https://conductscience.org/library/papers/42436714 | PubMed |
| 42238232 | Role of diffusion-weighted magnetic resonance imaging and apparent diffusion coefficient in subtyping renal cell carcinoma. | World J Radiol | 2026 | https://conductscience.org/library/papers/42238232 | PubMed |
| 42212433 | Updates and controversies in contemporary grading of clear cell renal cell carcinoma and papillary renal cell carcinoma. | Histopathology | 2026 | https://conductscience.org/library/papers/42212433 | PubMed |
| 41975702 | Pathology-Driven Genomic Panels for Personalized Prognostic Stratification and Exploratory Therapeutic Prediction in Clear-Cell Renal Cell Carcinoma with Tumor Thrombus. | Diagnostics (Basel) | 2026 | https://conductscience.org/library/papers/41975702 | PubMed |
| 41913822 | Hidden in Plain Sight: Metastatic Renal Cell Carcinoma Masquerading as Multinodular Thyroid Disease. | Cureus | 2026 | https://conductscience.org/library/papers/41913822 | PubMed |
| 41898704 | Targeting G6PD (Glucose-6-Phosphate Dehydrogenase) as a Biomarker of Therapeutic Vulnerability in Renal Cell Carcinoma. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41898704 | PubMed |
| 41871874 | Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of renal cell carcinoma, version 3.0. | J Immunother Cancer | 2026 | https://conductscience.org/library/papers/41871874 | PubMed |
| 41841143 | Does Tumor Grade Have any Prognostic Significance in Chromophobe Renal Cell Carcinoma: A Clinicopathological Study. | J Cancer Allied Spec | 2025 | https://conductscience.org/library/papers/41841143 | PubMed |
| 41840584 | TCOF1 affects Golgi secretory pathway contributing to the angiogenesis in renal cancer. | Cell Commun Signal | 2026 | https://conductscience.org/library/papers/41840584 | PubMed |
| 41732251 | Metastatic renal cell carcinoma: risk of rapid progression to pathological fractures and factors influencing post-treatment survival - a Swedish Nationwide cohort study. | J Bone Oncol | 2026 | https://conductscience.org/library/papers/41732251 | PubMed |
| 41614853 | A PDCD4-Based Gene Expression Signature Predicts Overall Survival in Renal Cell Carcinoma: A TCGA-Based Discovery and External Validation Study. | Curr Issues Mol Biol | 2025 | https://conductscience.org/library/papers/41614853 | PubMed |
| 41503066 | pVHL status in clear cell renal cell carcinoma regulates HIF-α and E-cadherin expression levels and their implications for tumor progression. | Ups J Med Sci | 2025 | https://conductscience.org/library/papers/41503066 | PubMed |
| 41472921 | Artificial intelligence-driven digital pathology in urological cancers: current trends and future directions. | Prostate Int | 2025 | https://conductscience.org/library/papers/41472921 | PubMed |
| 41083961 | The association between serum uric acid and survival outcomes in patients with metastatic renal cell carcinoma treated with targeted therapy. | BMC Cancer | 2025 | https://conductscience.org/library/papers/41083961 | PubMed |
| 41057662 | Diagnosis and grading of adrenal cortical carcinoma. | Virchows Arch | 2026 | https://conductscience.org/library/papers/41057662 | PubMed |
| 41010935 | Impact of Adipokine Expression on Tumor Characteristics and Survival Outcomes in Patients with Renal Cell Carcinoma. | Medicina (Kaunas) | 2025 | https://conductscience.org/library/papers/41010935 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7180965
GET https://conductscience.org/api/papers/v1/7180965/cited_by?page=2